Fig. 1From: Synthesis and evaluation of a novel PET ligand, a GSK’963 analog, aiming at autoradiography and imaging of the receptor interacting protein kinase 1 in the brainReceptor-interacting protein kinase 1 (RIPK1) inhibitorsBack to article page